Clinical Pharmacology Tobacco Core Services and Rates
Rates Effective July 1, 2020 through June 30, 2022
|Method||Cancer Center* Rate||UCSF Recharge||External Non-industry||External Industry|
LC-MS/MS. Straightforward Sample Prep and Data Analysis: ex. Cotinine/3HC, or Anabasine/Anatabine, or NNN/NNK, Nicotelline, THC and 11-Hydroxy-THC (metabolite) in plasma, 11-Nor-9-carboxy-THC (THC-COOH, metabolite) in urine
LC-MS/MS. Moderate Sample Prep/Data Analysis: ex. Bupropion and Bupropion Metabolites, or Caffeine and Caffeine Metabolites
LC-MS/MS. Complex Sample Prep/Data Analysis: such as: NNAL; or PAH Metabolites; or Mercapturic acid metabolites; or Total Nicotine Equivalents
GC-MS/MS, Triple Quadrupole MS: ex Low-Level Nicotine, or PAHs
Matrix Digestion Surcharge
* The Cancer Center rate, available to official members and associate members of the Cancer Center, is calculated as 60 percent of the regular UCSF recharge rate, with the differential paid from Cancer Center funds. (For reference, a list of Cancer Center members is available here.)
Note: Category D has been phased out due to lack of use.
Publications generated from use of this facility should appropriately acknowledge the UCSF Helen Diller Family Comprehensive Cancer Center Tobacco Biomarkers Core.
The UCSF Clinical Pharmacology Laboratory is a research facility and does not report patient specific results for the diagnosis, prevention or treatment of any disease or impairment of, or the assessment of the health of, individual patients. Results of analyses carried out by this laboratory may not be used for purposes of litigation and may not be used as evidence in a court of law.
A searchable database of core facilities at all UCSF campus locations, provided by the Clinical and Translational Science Institute at UCSF, is available here.